Abstract
Background: Atherosclerosis is the leading cause of death and morbidity throughout industrialized nations, accounting for one-fifth of all deaths globally. Exosomes are bi-lipid membranous vesicles containing protein, lipid and nucleic acid contents that are released from the cells via the endolysosomal pathway. Exosomes are derived from several cells including macrophages, dendritic cells, platelets as well as human serum.
Methods: In this review, an overview of recent advances, the evidence for the role of exosomes and exosomederived microRNAs (miRNAs) in atherosclerosis are provided.
Results: Recent evidence has shown that exosomes derived from the cells mentioned above are involved in atherosclerosis, whose secretion appears to be regulated by various natural and experimental stimuli, physiological and pathological processes.
Conclusion: Exosomes are now accepted as specifically secreted vesicles that enable intercellular communications and have become exponentially interesting to be used as the possible relevant biomarkers in disease development such as cadiovascular disease, particular in atherosclerosis in addition to their minimally invasive clinical diagnosis.
Keywords: Atherosclerosis, exosome, microRNA, MMP, CVD, vesicles.
Current Pharmaceutical Design
Title:The Role of Exosomes and Exosome-derived microRNAs in Atherosclerosis
Volume: 23 Issue: 40
Author(s): Xinjie Lu*
Affiliation:
- The Mary and Garry Weston Molecular Immunology Laboratory, Thrombosis Research Institute, London, SW3 6LR,United Kingdom
Keywords: Atherosclerosis, exosome, microRNA, MMP, CVD, vesicles.
Abstract: Background: Atherosclerosis is the leading cause of death and morbidity throughout industrialized nations, accounting for one-fifth of all deaths globally. Exosomes are bi-lipid membranous vesicles containing protein, lipid and nucleic acid contents that are released from the cells via the endolysosomal pathway. Exosomes are derived from several cells including macrophages, dendritic cells, platelets as well as human serum.
Methods: In this review, an overview of recent advances, the evidence for the role of exosomes and exosomederived microRNAs (miRNAs) in atherosclerosis are provided.
Results: Recent evidence has shown that exosomes derived from the cells mentioned above are involved in atherosclerosis, whose secretion appears to be regulated by various natural and experimental stimuli, physiological and pathological processes.
Conclusion: Exosomes are now accepted as specifically secreted vesicles that enable intercellular communications and have become exponentially interesting to be used as the possible relevant biomarkers in disease development such as cadiovascular disease, particular in atherosclerosis in addition to their minimally invasive clinical diagnosis.
Export Options
About this article
Cite this article as:
Lu Xinjie *, The Role of Exosomes and Exosome-derived microRNAs in Atherosclerosis, Current Pharmaceutical Design 2017; 23 (40) . https://dx.doi.org/10.2174/1381612823666170413125507
DOI https://dx.doi.org/10.2174/1381612823666170413125507 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Distribution of Left Ventricular Thrombus among Patients with Significantly Impaired Systolic Function
New Emirates Medical Journal Current Status of CETP Inhibitors in the Treatment of Hyperlipidemia: An Update
Current Clinical Pharmacology Decreased Vascular Repair and Neovascularization with Ageing: Mechanisms and Clinical Relevance with an Emphasis on Hypoxia- Inducible Factor-1
Current Molecular Medicine Cardiovascular Alterations After Spinal Cord Injury: An Overview
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Designing Type II Topoisomerase Inhibitors: A Molecular Modeling Approach
Current Topics in Medicinal Chemistry Bilosomes: A Novel Approach to Meet the Challenges in Oral Immunization
Recent Patents on Drug Delivery & Formulation Asymmetric Dimethylarginine: a Key Player in the Pathophysiology of Endothelial Dysfunction, Vascular Inflammation and Atherosclerosis in Rheumatoid Arthritis?
Current Pharmaceutical Design To Die or Not to Die: That is the Autophagic Question
Current Molecular Medicine Radiolabelled Oligonucleotides for Imaging of Gene Expression with PET
Current Medicinal Chemistry Renovascular Hypertension: Lesion Detection, Patient Selection, Treatment Options and Results
Current Hypertension Reviews Pharmacogenomics: A Tool to Prevent and Cure Coronary Heart Disease
Current Pharmaceutical Design Non-Alcoholic Fatty Liver Disease in the Metabolic Syndrome
Current Pharmaceutical Design Recent Patents in Cardiac Resynchronization Therapy
Recent Patents on Biomedical Engineering (Discontinued) Obesity-Induced Hypertension: New Insights
Current Pharmaceutical Design Management of Spasticity in Progressive Multiple Sclerosis: Efficacy of Repeated Intrathecal Triamcinolone Acetonide Administration
Current Pharmaceutical Design Mitochondria in Cancer Stem Cells: A Target for Therapy
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Trastuzumab-Induced Cardiotoxicity: Is it a Personalized Risk?
Current Drug Targets The Impact of Various Blood Pressure Measurements on Cardiovascular Outcomes
Current Vascular Pharmacology A Systematic Review of Randomized Controlled Trials Examining the Nephroprotective Properties of Antihypertensive Medications
Current Hypertension Reviews Biomarkers of Atrial Fibrillation in Metabolic Syndrome
Current Medicinal Chemistry